NICOTINE PATCHES Nicotinell 14mg 28 24H is a drug treating tobacco dependence. Patches 14mg / 24h Nicotinell relieve the symptoms of nicotine withdrawal, are used early in the treatment of moderate smokers or intermediate phase of heavy smokers.
Available expedié in 1-2 business days
Warning: Last items in stock!
Availability date:Preview the Shipping Fees - Free Shipping from 99€*
For the warnings, the precautions and cons-indications, see the instructions.
NICOTINE PATCHES Nicotinell 14mg 28 24H
Description Nicotinell 14mg NICOTINE PATCHES 28 24H
Patch Nicotinell 14mg / 24h Novartis laboratories is a medicine that contains nicotine, only for adults from 15 years and indicated for the treatment of tobacco dependence in order to alleviate the symptoms of nicotine withdrawal in patients wishing to stop tobacco use.
After application of the patch, the nicotine contained is gradually released and pass into the bloodstream through the skin.
No contact with other harmful substances contained in tobacco cigarettes (carbon monoxide, tar, stimulants gas ...).
Nicotine decreases withdrawal symptoms (pressing a cigarette craving, irritability, moodiness, anxiety, feelings of fear, hunger, weight gain, difficulty concentrating, sleep disturbances ...).
Very discreet, Nicotinell Patch 14mg / 24h is for the early treatment of moderate smokers (including cigarette consumption does not exceed 20 cigarettes per day) or intermediate processing heavy smokers (including cigarette smoking than 20 cigarettes per day). It continuously releases (over 24 hours) of nicotine and thus reduces the urgent desire of the first cigarette in the morning. It helps to stop smoking, reduces the unpleasant effects of deprivation and the craving.
Using advice and opinion on Nicotinell 14mg NICOTINE PATCHES 28 24H
Nicotinell Patch 14mg / 24h sticks once a day and will remain 24 hours on the skin:
Change the location each day to avoid skin irritation.
Remove the protective sheet.
Apply the patch to clean skin, smooth, dry, healthy (without traces of lotions, alcohol or ointment), preferably on the chest or upper arm.
Hold the patch by pressing with the palm of the hand for about 10 seconds.
During handling, avoid contact with eyes, nose and wash your hands after application.
Heavy smokers (including cigarette smoking than 20 cigarettes per day):
Nicotinell Patch 21mg / 24 hours over a period of about 4 weeks and then Nicotinell Patch 14mg / 24 hours over a period of 4 weeks and then additional Nicotinell Patch 14mg / 24h for a duration of about 4 weeks.
Smokers with an average consumption (including cigarette consumption does not exceed 20 cigarettes a day.)
Nicotinell Patch 14mg / 24 for 8 weeks or so, then Nicotinell Patch 14mg / 24h for approximately 4 weeks.
The dosage of the transdermal system should be tailored to the individual response: increase dose if smoking abstinence is not complete or if withdrawal symptoms are observed, reduction in overdose is suspected.
The duration of treatment is about 3 months, but may vary depending on the individual response. It is recommended not to use this medication beyond 6 months.
Teenagers should use Nicotinell Patch in case of heavy dependence on tobacco and after consulting a doctor or pharmacist.
Composition Nicotinell 14mg NICOTINE PATCHES 28 24H
1 Patch Nicotinell contains 35 mg of nicotine - The mean release of active ingredient on the skin is 14 mg / 24 h.
A transdermal device (20 cm²): S (-) Nicotine 35 mg. Excipients: copolymer alkaline methacrylate (Eudragit E 100) qs 1 patch. Outer shell: polyester film. Layer of the matrix: DuroTak 280-2516, Miglyol 812, Eudragit E 100. Support nonwoven: paper. Adhesive layer: DuroTak 280-2516, 812. miglyol removable protective sheet: silicone aluminized polyester film.
Use caution with Nicotinell 14mg NICOTINE PATCHES 28 24H
This medicine is against-indicated in the following situations: Non-smoker or occasional smoker; Hypersensitivity to any component; Skin condition that may interfere with the use of a patch.
Nicotinell presentation NICOTINE PATCHES 14mg 28 24H
Box of 28 Patches Nicotinell 14mg / 24h.
Our expert advice in pharmacy
Warnings and other precautions for use:
To ensure the best chance of success, the use of this drug should be accompanied by a complete cessation of smoking.
Due to the pharmacological effects of nicotine, some diseases require medical advice and medical supervision: Liver and / or severe renal impairment; gastric or duodenal ulcer changing.
Nicotine is a toxic substance: Keep this medicine out of reach of children. In fact, the therapeutic dose intended for adults might cause serious poisoning or death in children.
It is recommended to fold the patch on himself before discarding.
If severe or persistent skin reaction, it is recommended to stop the treatment and use another pharmaceutical form (see Adverse Reactions).
Experimental studies in several species have shown no teratogenic or foetotoxic effect of nicotine administered with continuous flow, and this at maternally toxic doses. Under the same conditions of administration, fetal growth retardation is observed at even higher doses in one case, the mice but not in rats or rabbits. Clinically, yet limited number of observations show no deleterious impact, maternal or fetal, nicotine used in the indication of smoking cessation.
Smoking during pregnancy may be the cause of intrauterine growth retardation, fetal death in utero, a premature birth, small for gestational age, which seem to correlate with the importance of impregnation smoking and the period of pregnancy, as these effects are observed when smoking impregnation continues for the third quarter.
Nicotine provided by substitution treatment is not without deleterious effects on the fetus, as demonstrated by the hemodynamic consequences observed. However, it has no epidemiological study indicating the actual impact of nicotine provided by substitution treatment on the fetus or newborn.
In pregnant women, should always recommend a complete stop smoking without replacement therapy to nicotine.
In case of failure at a highly dependent patient, smoking cessation is possible with this medication. Indeed, the risk to the fetus, if continued smoking during pregnancy is probably higher than expected with nicotine replacement therapy, as is superimposed with tobacco exposure to polycyclic hydrocarbons and the carbon monoxide, and since nicotine exposure provided by the substitution treatment is less than or is not greater than that associated with tobacco consumption.
The goal is to achieve complete cessation or even substitution treatment, before the third trimester of pregnancy. Smoking cessation, with or without substitution treatment, should not be considered in isolation, but within the framework of a comprehensive care, taking into account the psycho-social context and other addictions optionally combined. It may be desirable to use a consultation specializing in smoking cessation.
In case of partial or complete failure of weaning, continued treatment with a nicotine substitute after the 6th month of pregnancy can only be considered case by case. One should keep in mind the specific effects of nicotine, which might sound on the fetus, especially when near term.
Given the consistency of nicotine concentrations with this form of substitution, breastfeeding is not recommended during treatment with this medicine.
Interaction with other medicinal products and other forms of interaction:
Tobacco may, by enzyme induction process due to aromatic hydrocarbons, decrease blood levels of certain drugs such as caffeine, theophylline, tricyclic antidepressants, flecainide, pentazocine.
The decision, a fortiori brutal, tobacco, especially on the occasion of taking this medicine, may increase the concentrations of these active ingredients, linked to the reversibility of the effect of enzyme induction.
For drugs with narrow therapeutic index, such as theophylline, smoking cessation should be accompanied, in addition to dose adjustment, a narrow, clinical or biological monitoring, information to the patient with risk of overdose.
Its specific, cardiovascular, neurological and endocrine pharmacological properties, nicotine may, like tobacco: result in increased concentrations of cortisol and catecholamines; require a dosage adjustment of nifedipine, beta blockers, insulin; reduce the effect of diuretics; slowing the rate of healing of gastric ulcers by H2 antihistamines; increase the incidence of adverse estroprogestatifs.
Transdermal nicotine can cause side effects similar to nicotine administered by other modes.
Systemic side effects: palpitations. Dizziness, headache. Nausea, vomiting. Insomnia, blurred dreamlike.
Local side effects: erythema and itching at the application site, rarely edema, burning sensation.
These effects are largely moderate majority and resolve spontaneously soon after system removal.
If severe or persistent skin reaction, it is recommended to stop the treatment and use another form of nicotine replacement.
Some symptoms such as dizziness, headache and insomnia may be related to smoking cessation.
An increase in the occurrence of oral ulcers can occur after smoking cessation. The causal relationship is not clear.
Nicotine overdose can occur if the patient had previously dealt with very low nicotine intake or if concomitant use of other treatments for smoking cessation based nicotine.
Overdose symptoms are those of acute nicotine poisoning include nausea, salivation, abdominal pain, diarrhea, sweating, headache, dizziness, loss of hearing and general weakness. At high doses can appear hypotension, weak and irregular pulse, breathing difficulties, prostration, circulatory collapse and convulsions.
The doses of nicotine tolerated by smoking subjects during treatment can cause acute poisoning can be fatal in young children.
What to do in case of overdose:
The nicotine administration should be discontinued immediately and symptomatic treatment should be initiated.
Assisted ventilation and oxygen therapy will be initiated if necessary.
Warnings on drugs
Attention, the drug is not a product like any other. Read the package leaflet before ordering. Do not let the drugs out of reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your current products.
Please tell your online pharmacist ongoing treatment to identify any incompatibilities. The order confirmation form contains a custom message field provided for this purpose.
Click here to find the manual for this product on the website of the National Agency for Drug Safety and health products.
Pharmacovigilance : Reporting an or effect (s) junk (s) connected (s) to the use of a drug
Save time by using the quick order form. With a few clicks , you can easily order your favorite references.
Be fan of our Facebook page and get 5 % discount!
If you are not logged in to Facebook, please first log in and then refresh this page before clicking the Like button. Otherwise, you will not get your voucher.